2026 Johnson & Johnson Innovative Medicine Commercial Leadership Development Program (CLDP) Full-Time

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com

Job Function:

Career Programs

Job Sub Function:

Commercial LDP – Pharm

Job Category:

Career Program

All Job Posting Locations:

Horsham, Pennsylvania, United States of America, Raritan, New Jersey, United States of America, Titusville, New Jersey, United States of America

Job Description:

About Innovative Medicine

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

Learn more at https://www.jnj.com/innovative-medicine

An internal pre-identified candidate for consideration has been identified. However, all applications will be considered.

We are searching for the best talent for the 2026 Johnson & Johnson Innovative Medicine Commercial Leadership Development Program (CLDP) Full-Time

Purpose: Johnson & Johnson is recruiting MBA talent passionate about exploring a career in healthcare for their Leadership Development Full-Time program with a focus on Commercial Leadership roles.

Johnson & Johnson’s Full-Time CLDP program consists of diverse rotations in marketing, market access, new product business development and other key commercial functions to prepare you as a future business leader at Johnson & Johnson. All rotations are North America based and supplemented by classroom and e-learning training over the program. Training covers all areas critical to success at J&J and delivered by program leadership, key commercial pharmaceutical leaders, J&J Executives, and external consultants.

The Full-time opportunity is in the greater Horsham, PA, Titusville, NJ or Raritan, NJ area (depending on team assignment).

Qualifications / Requirements:

Required

• U.S. work authorization without the need for sponsorship for employment visa status. (e.g., H1-B status) now or in the future. (Students currently in the country on CPT, OPT, or STEM OPT require future sponsorship for long term employment).

• Be enrolled in an accredited MBA Program with graduation planned no later than July 2026.

• Ability to relocate to assigned site location (candidate preference will be considered).

• A minimum of 4 years of work experience and/or military experience (5 years preferred).

• Passion for improving Healthcare.

• Exceptional interpersonal and presentation skills.

• Ability to think strategically, and influence and execute a plan effectively.

• Validated analytical skills and cycles of success in a professional business environment.

• Ability to make Credo-based decisions and develop a Credo-based culture.

Preferred

• A concentration in Healthcare Management or Marketing.

• Prior experience in the CLDP summer internship program.

• Experience in healthcare, marketing, sales, business analytics and/or management consulting in health care related field.

• Project management skills and ability to navigate a matrix organization to accomplish goals.

• Collaboration with key internal and external partners in support of project outcomes.

• Development of significant partnerships to add value and insights for the organization.

• Act with speed, learning agility and intellectual curiosity.

• Clear and concise communication and presentation skills.

This job posting is anticipated to close on November 7th, 2025. The Company may however extend this time-period, in which case the posting will remain available on